Literature DB >> 20191516

RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ (Multidimensional Health Assessment Questionnaire): agreement with DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) activity categories, scored in five versus more than ninety seconds.

Theodore Pincus1, Christopher J Swearingen, Martin J Bergman, C Lee Colglazier, Alan T Kaell, Arthur M Kunath, Evan L Siegel, Yusuf Yazici.   

Abstract

OBJECTIVE: To compare the Routine Assessment of Patient Index Data 3 (RAPID3) on a Multidimensional Health Assessment Questionnaire (MDHAQ) with the Disease Activity Score (DAS28), Clinical Disease Activity Index (CDAI), and individual core data set measures for correlations, agreement of activity levels, and time to score.
METHODS: Four rheumatologists each assessed 50 patients with rheumatoid arthritis in "real-time" clinical care. Patients completed an MDHAQ. The rheumatologist then calculated RAPID3 (physical function, pain, patient global estimate), performed a 28-joint count, assigned a physician global estimate, and scored a CDAI, each timed by an observer. Erythrocyte sedimentation rate (ESR) was tested on the same date, and the DAS28-ESR was computed later, again timed by an observer. Spearman's rank-order correlations and comparisons of patients classified as high activity, moderate activity, low activity, and remission according to the DAS28, CDAI, and RAPID3 were computed and compared with kappa statistics. A second study of 25 "paper patients" was also performed to compare time to score the DAS28, CDAI, and RAPID3 on a 0-10 versus 0-30 scale. Mean and median times to score each index were computed.
RESULTS: The 3 indices were correlated significantly, including agreement for >80% of patients for high/moderate activity. The mean time to perform a 28-joint count was 94 seconds, and the mean times to score the DAS28, CDAI, RAPID3 on a 0-10 scale, and RAPID3 on a 0-30 scale were 114, 106, 9.6, and 4.6 seconds, respectively.
CONCLUSION: RAPID3 scores provide similar quantitative information to DAS28 and CDAI, while calculated on a 0-30 scale in about 5% of the time.

Entities:  

Mesh:

Year:  2010        PMID: 20191516     DOI: 10.1002/acr.20066

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  29 in total

1.  Five-year changes in cardiac structure and function in patients with rheumatoid arthritis compared with the general population.

Authors:  John M Davis; Grace Lin; Jae K Oh; Cynthia S Crowson; Sara J Achenbach; Terry M Therneau; Eric L Matteson; Richard J Rodeheffer; Sherine E Gabriel
Journal:  Int J Cardiol       Date:  2017-03-31       Impact factor: 4.164

Review 2.  Patient reported outcomes in rheumatoid arthritis clinical trials.

Authors:  Ana-Maria Orbai; Clifton O Bingham
Journal:  Curr Rheumatol Rep       Date:  2015-04       Impact factor: 4.592

Review 3.  Use of biologics in rheumatoid arthritis: current and emerging paradigms of care.

Authors:  Jeffrey R Curtis; Jasvinder A Singh
Journal:  Clin Ther       Date:  2011-06       Impact factor: 3.393

4.  Correlation between rapid-3, DAS28, CDAI and SDAI as a measure of disease activity in a cohort of Colombian patients with rheumatoid arthritis.

Authors:  Jesus Giovanny Ballesteros Muñoz; Rodrigo B Giraldo; Ana M Santos; Juan Manuel Bello-Gualteros; Juan C Rueda; Eugenia-Lucia Saldarriaga; Jose-Ignacio Angarita; Sofia Arias-Correal; Andres Y Vasquez; John Londono
Journal:  Clin Rheumatol       Date:  2016-12-24       Impact factor: 2.980

5.  Routine Assessment of Patient Index Data 3 score (RAPID3) correlates well with Bath Ankylosing Spondylitis Disease Activity index (BASDAI) in the assessment of disease activity and monitoring progression of axial spondyloarthritis.

Authors:  Abhijeet Danve; Anusha Reddy; Kiana Vakil-Gilani; Neha Garg; Alexis Dinno; Atul Deodhar
Journal:  Clin Rheumatol       Date:  2014-11-26       Impact factor: 2.980

6.  A patient-reported outcome measures-based composite index (RAPID3) for the assessment of disease activity in ankylosing spondylitis.

Authors:  Muhammet Cinar; Sedat Yilmaz; Fatma Ilknur Cinar; Suleyman Serdar Koca; Hakan Erdem; Salih Pay; Ayhan Dinc; Yusuf Yazici; Ismail Simsek
Journal:  Rheumatol Int       Date:  2015-03-21       Impact factor: 2.631

7.  RAPID3 scores and hand outcome measurements in RA patients: a preliminary study.

Authors:  Merita Qorolli; Hajrije Hundozi-Hysenaj; Sylejman Rexhepi; Blerta Rehxepi; Simeon Grazio
Journal:  Clin Rheumatol       Date:  2016-12-28       Impact factor: 2.980

8.  Evaluation of disease activity in rheumatoid arthritis by Routine Assessment of Patient Index Data 3 (RAPID3) and its correlation to Disease Activity Score 28 (DAS28) and Clinical Disease Activity Index (CDAI): an Indian experience.

Authors:  H Singh; V Gupta; S Ray; H Kumar; P Talapatra; M Kaur; S Kumar; S Arya; R Mathur; N Ghangas
Journal:  Clin Rheumatol       Date:  2012-09-15       Impact factor: 2.980

9.  Performance of Routine Assessment of Patient Index Data 3 (RAPID3) for assessment of rheumatoid arthritis in clinical practice: differential agreement of RAPID3 according to disease activity categories.

Authors:  Seong-Kyu Kim; Sung-Hoon Park; Jisuk Bae; Jung Tae Son; Jung-Yoon Choe
Journal:  Rheumatol Int       Date:  2014-05-15       Impact factor: 2.631

10.  Usefulness of patients-reported outcomes in rheumatoid arthritis focus group.

Authors:  Jenny Amaya-Amaya; Diana Botello-Corzo; Omar-Javier Calixto; Rolando Calderón-Rojas; Aura-Maria Domínguez; Paola Cruz-Tapias; Gladis Montoya-Ortiz; Ruben-Dario Mantilla; Juan-Manuel Anaya; Adriana Rojas-Villarraga
Journal:  Arthritis       Date:  2012-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.